An experience of Retinalamin use in glaucomatous optic neuropethy and age-related macular degeneration
Ophthalmology Reports · 15.06.2013 · 6 (2) · 45-49
DOI: 10.17816/ov2013245-49 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ophthalmology Reports, online erschienen am 15.06.2013. Verfasst von Yury Sergeevich Astakhov und 4 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
From 2005, an estimation of possible neuroprotective cytomedine Retinalamin action was carried out using objective investigation methods in patients with primary open-angle glaucoma stage 1 and 2 and in those with dry AMD, both being debilitating ophthalmic conditions.
Zitieren
APA
Astakhov, Y. S., Butin, Y. V., Morozova, N. V., Sokolov, V. O., & Florentseva, S. S. (2013). An experience of Retinalamin use in glaucomatous optic neuropethy and age-related macular degeneration. Ophthalmology Reports, 6(2), 45-49. https://doi.org/10.17816/ov2013245-49
Vancouver
Astakhov YS, Butin YV, Morozova NV, Sokolov VO, Florentseva SS. An experience of Retinalamin use in glaucomatous optic neuropethy and age-related macular degeneration. Ophthalmology Reports. 2013;6(2):45-49. doi:10.17816/ov2013245-49
BibTeX
@article{Astakhov2013,
author = {Astakhov, Yury Sergeevich and Butin, Yevgeniy Vladimirovich and Morozova, Natalia Vladimirovna and Sokolov, Vitaliy Olegovich and Florentseva, Svetlana Sergeevna},
title = {An experience of Retinalamin use in glaucomatous optic neuropethy and age-related macular degeneration},
journal = {Ophthalmology Reports},
year = {2013},
volume = {6},
number = {2},
pages = {45--49},
doi = {10.17816/ov2013245-49}
}
EUVIMED